Sands Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$143M Sell
2025
Q1
$151M Sell
2024
Q4
$181M Sell
2024
Q3
$284M Sell
2024
Q2
$220M Buy
2024
Q1
$180M Sell
2023
Q4
$197M Buy
2023
Q3
$91.9M Sell
2023
Q2
$123M Buy